Skip to main content
NIH funding notice PAR-23-148

Pulmonary Outcomes and Sequelae after Treatment-TB (POST-TB) (R01 Clinical Trial Optional)

Closed on May 23, 2025.

Posted
March 30, 2023
Close date
May 23, 2025
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,009,148 in first-year total cost, median $743,698.

Most frequent study sections

  1. HIV Coinfections and HIV Associated Cancers Study Section[HCAC]3

Most frequent institutions

  1. BOSTON UNIVERSITY MEDICAL CAMPUS1
  2. INDIANA UNIVERSITY INDIANAPOLIS1
  3. JOHNS HOPKINS UNIVERSITY1
Competing awards under PAR-23-148 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Post-Tuberculosis Lung Disease in Youth with and without HIV Globally1R01AI184174-01A1ENANE, LESLIE ANNEINDIANA UNIVERSITY INDIANAPOLIS, IN$790,320HCAC
2025Causality of Post-TB Lung Disease: Population-Level Evidence from Rural Uganda1R01AI186761-01A1CHECKLEY, WILLIAMDOWDY, DAVID WESLEYGALIWANGO, RONALD MOSESJOHNS HOPKINS UNIVERSITY, MD$475,130HCAC
2024Interleukin-6 signaling, lung injury, and post-TB lung disease in TB-HIV1R01AI184179-01CHRISTOPHER, DEVASAHAYAM JESUDASGUPTE, AKSHAY NITINBOSTON UNIVERSITY MEDICAL CAMPUS, MA$743,698HCAC

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-23-148: Pulmonary Outcomes and Sequelae after Treatment-TB (POST-TB) (R01 Clinical Trial Optional) | ScienceDex | ConductScience